Unique Lessons From the Natural Progression of Rejection in Human Uterine Allografts
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15434 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Liza Johannesson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Abdominal Transplantation, Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Graft Rejection, Uterus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Baylor Scott & White Health, University of Pittsburgh, Baylor Scott and White Health.
Abstract (Originalsprache)
Introduction
Uterus transplantation (UTx) is a novel treatment for absolute uterine infertility. Acute T cell–mediated rejection (TCMR) can be monitored only through serial cervical biopsies.
Methods
This study, the first of its kind in human transplantation, evaluated clinical, serological, and pathophysiological manifestations of allograft rejection from immunosuppression withdrawal (ISW) to graft hysterectomy (Hx).
Results
Following live birth, immunosuppression was abruptly withdrawn from six living‐donor UTx recipients. ISW occurred at a median of 7.4 weeks before graft Hx. Post‐ISW signs of rejection included: (1) discoloration of the cervix; (2) increased uterine size compared to day of ISW; (3) serological evidence of eosinophilia and progressive development of donor‐specific antibodies (DSA) or child‐specific antibodies (CSA); (4) histopathological evidence of TCMR in cervical biopsies preceding the development of antibodies in serum; and (5) C4d deposition in tissue before formation of DSA or CSA in all but two recipients. At graft Hx, endometrial glands were preferentially targeted for destruction over stroma while parametrial arteries displayed variable arteritis and fibrointimal hyperplasia.
Conclusion
Recognition of the progression of uterine allograft rejection may be important for other human organ recipients and drive research on modulation of immunosuppression and the paradoxical relationship between adaptive cellular and humoral immunity in natural pregnancies. Trial Registration ClinicalTrials.gov identifier: NCT02656550
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Abdominal Transplantation, Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, Texas, USA.
- Department of Pathology, Division of Hepatic and Transplantation Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- Department of Pathology, Baylor University Medical Center, Dallas, Texas, USA.
- Transplant Immunology Laboratory, Baylor University Medical Center, Dallas, Texas, USA.
- College of Medicine & Qatar University Health, Qatar University, Doha, Qatar.
ORCID-Profile: Liza Johannesson, Michelle A Wood-Trageser, Bashoo Naziruddin, Medhat Askar, Giuliano Testa
Förderung
- Baylor Scott & White Health
- University of Pittsburgh
- Baylor Scott and White Health
Zitieren
APA
Johannesson, L., Wood-Trageser, M. A., Lesniak, D., Punar, M., Klingman, L., Naziruddin, B., Askar, M., Demetris, A. J., & Testa, G. (2024). Unique Lessons From the Natural Progression of Rejection in Human Uterine Allografts. Clinical Transplantation. https://doi.org/10.1111/ctr.15434
Vancouver
Johannesson L, Wood-Trageser MA, Lesniak D, Punar M, Klingman L, Naziruddin B, et al. Unique Lessons From the Natural Progression of Rejection in Human Uterine Allografts. Clinical Transplantation. 2024. doi:10.1111/ctr.15434
BibTeX
@article{Johannesson2024,
author = {Johannesson, Liza and Wood-Trageser, Michelle A and Lesniak, Drew and Punar, Metin and Klingman, Lynne and Naziruddin, Bashoo and Askar, Medhat and Demetris, Anthony J and Testa, Giuliano},
title = {Unique Lessons From the Natural Progression of Rejection in Human Uterine Allografts},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15434}
}
EUVIMED